Theratechnologies Inc T.TH

We are just cheerleaders now

[jeffm34]

Since we just gave up our right to complain anymore I guess we are resigned to being cheer leaders now. 

Paul and Dawn you have done an amazing job. Don't change a thing ! There is no one else outside of Montreal that could possibly be of any help to the company. Keep up the awesome work.

[Bucknelly21]

Lol

[SPCEO1]

The idea that nothign has changed is incorret. Our pressure campaign actually worked and they are spending more money on the investor relations function and planning on adding someone with US capital markets experience to the board. They listened to us and took action. You may beleive it is not enough or they are the wrong people to carry out the changes, but each person gets to vote as they see

[jeffm34]

We won't know what changes they make and whether they are good enough until it's too late this time. There will be another raise coming soon. You don't start an expensive trial without having it fully funded. That means a raise or partnership coming soon. Are you comfortable doing another financing sub $4US ? 

[qwerty22]

1st April 2019 "“Data analysis is ongoing and Theratechnologies will quickly establish a strategy regarding the potential options now available for the continued development of tesamorelin,” said Luc Tanguay President and CEO of Theratechnologies." https://stockhouse.com/news/press-releases/2019/04/01/study-confirms-tesamorelin-significantly-reduces-liver-fat-in-hiv-patients-with

[SPCEO1]

A few points about the "stalled NASH program" 1. ) When they first reported those results, they did not even have the F4 version of Egrifta. There was no way the drug would be an effective competitor in even HIV NASH using the F1 injection. TH went form F1 to F4 and finally to F8 in the past two years and the F8 is really required to give Egrifta a chance in the NASH market. I doubt

[qwerty22]

Fine I'm over-stating things here more in a frustrated response to the ongoing conversation about messaging here than as a criticism of the company. I accept this has been a complex process for them. I also accept they've done lots of positive things in this time but a clinical program moves in phases and there are also the periods between phases and it's just a fact that we've

[scarlet1967]

Admittedly they have been slow maybe due to lack of resources so why adding members left and right now, why not bypassing the bonuses occasionally and use the funds to add to their resources in the areas they need it. As for the NASH has stalled I believe that's not correct to move from HIV to general market was a significant event to get both programs finalized and approved was another